Upgrades and Downgrades for Friday, 9/10

Upgrades

  • Editas Medicine (EDIT) upgraded by Oppenheimer from Perform to Outperform
  • Hudbay Minerals (HBM) upgraded by National Bank from Sector Perform to Outperform
  • Purplebricks (PRPPF) upgraded by UBS from Sell to Neutral
  • Allegion (ALLE) upgraded by Goldman Sachs from Neutral to Buy
  • Rexnord (RXN) upgraded by Goldman Sachs from Neutral to Buy
  • ASM International (ASMIY) upgraded by AlphaValue/Baader from Reduce to Add
  • Fabege (FBGGF) upgraded by DNB Markets from Hold to Buy
  • Newcrest Mining (NCMGY) upgraded by Macquarie from Neutral to Outperform
  • Dacian Gold (DCCNF) upgraded by Macquarie from Underperform to Outperform
  • Evolution Mining (CAHPF) upgraded by Macquarie from Underperform to Neutral
  • OceanaGold (OCANF) upgraded by Macquarie from Neutral to Outperform
  • CNO Financial (CNO) upgraded by Piper Sandler from Neutral to Overweight
  • Orchid Island Capital (ORC) upgraded by JonesTrading from Sell to Hold
  • Host Hotels (HST) upgraded by Argus from Hold to Buy

Downgrades

  • Snam (SNMRF) downgraded by Societe Generale from Buy to Hold
  • Colfax (CFX) downgraded by Goldman Sachs from Buy to Neutral
  • Dassault (DASTY) downgraded by Exane BNP Paribas from Neutral to Underperform
  • Shoprite (SRGHY) downgraded by Citi from Buy to Neutral
  • Fresenius Medical (FMS) downgraded by JPMorgan from Neutral to Underweight
  • easyJet (ESYJY) downgraded by AlphaValue/Baader from Buy to Add
  • Jupiter Mines (JMXXF) downgraded by Macquarie from Neutral to Underperform
  • Freeport McMoRan (FCX) downgraded by Credit Suisse from Neutral to Underperform
  • Apellis (APLS) downgraded by Wedbush from Outperform to Neutral
  • American Tower (AMT) downgraded by Oppenheimer from Outperform to Perform
  • Crown Castle (CCI) downgraded by Oppenheimer from Outperform to Perform
  • Equinix (EQIX) downgraded by Oppenheimer from Outperform to Perform
  • BNP Paribas (BNPQY) downgraded by JPMorgan from Overweight to Neutral
  • Kadmon (KDMN) downgraded by UBS from Buy to Neutral
  • Cigna (CI) downgraded by BofA from Buy to Underperform
This is the #1 Stock to Buy for the AI Tidal Wave [sponsor]
Marc Chaikin warned people about NVDA before its 2023 bull run - now he's naming his next pick or the AI tidal wave. Learn more here.

fly360

Upgrades & Downgrades provided by The Fly at http://www.thefly.com.  The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.